Patent ID: 9586903
Date: 2017-03-07
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method for the therapeutic treatment of depression, anxiety disorders, Parkinson's disease, dementia, Alzheimer's disease, Down syndrome, autism spectrum disorders, amyotrophic lateral sclerosis, multiple sclerosis and Huntington's disease, comprising administering to a patient in need thereof a therapeutically effective amount of a compound according formula (I) wherein R R R or is heterocycloalkyl, optionally substituted by ═O and lower alkyl, or, is —(CH or is hydrogen, lower alkyl, lower alkyl substituted by halogen, lower alkyl substituted by hydroxy, —NR—S(O) R R is hydrogen or lower alkyl; n is 0, 1 or 2; or, a pharmaceutically acceptable acid addition salt, or an enantiomer, a diastereomer or a mixture of enantiomers or diastereomers.